Home›Search›Recent Advances in Anti-Infective Drug Discovery

Recent Advances in Anti-Infective Drug Discovery

Bentham Science Publishers · United Arab Emirates · Est. 1998

ISSN2772-4352

SJR Q3✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.304

H-Indexi

SNIPi

0.346

Total Worksi

143

Total Citationsi

391

2yr Mean Citednessi

0.73

Open Impact Factor alternative

Aims & Scope

Subject areas: Drug Discovery; Infectious Diseases; Pharmacology (medical).

General Information

Country / RegionUnited Arab Emirates

Primary Language—

1st Year Published1998

Annual Volume~ 22 articles / year

StatusActive (last: 2026)

Total Publications143

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/11 · 36%

✅

Do you know the journal / publisher?

Bentham Science Publishers

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2772-4352

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2020

139

2021

149

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ3

Infectious DiseasesQ3

Pharmacology (medical)Q3

Subject Classification

Scopus Categories

Drug DiscoveryPharmacology (medical)Infectious Diseases

Research Topics (OpenAlex)

COVID-19 Clinical Research StudiesDiverse Scientific and Economic StudiesDiverse Scientific Research StudiesSARS-CoV-2 and COVID-19 ResearchAntibiotic Resistance in BacteriaAntibiotic Use and ResistanceSynthesis and biological activityNail Diseases and TreatmentsHuman auditory perception and evaluationAntifungal resistance and susceptibility

Frequently asked questions about Recent Advances in Anti-Infective Drug Discovery

Is Recent Advances in Anti-Infective Drug Discovery a predatory journal?

PubScope has no integrity flags on record for Recent Advances in Anti-Infective Drug Discovery: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Recent Advances in Anti-Infective Drug Discovery?

Recent Advances in Anti-Infective Drug Discovery is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.304.

Is Recent Advances in Anti-Infective Drug Discovery indexed in Scopus and Web of Science?

Recent Advances in Anti-Infective Drug Discovery is indexed in Scopus.

What is the aims and scope of Recent Advances in Anti-Infective Drug Discovery?